Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.24.1.1.u2
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenues, net $ 3,634 $ 19,303  
Cost of revenue 4,067 8,783  
Depreciation and amortization expense 1,605 1,237  
Operating and other expenses 6,793 8,719  
Income (loss) from operations, before income taxes (8,831) 564  
Income tax benefit (expense) 2,566 (14)  
Total (loss) income from operations, after income taxes (6,265) 550  
Net (loss) income (6,265) 550  
Total assets 90,032   $ 91,927
Diagnostic services      
Segment Reporting Information [Line Items]      
Revenues, net 0 14,524  
Cost of revenue 720 5,222  
Depreciation and amortization expense 801 931  
Income (loss) from operations, before income taxes (3,345) 4,397  
Total assets 42,296   44,221
Consumer products      
Segment Reporting Information [Line Items]      
Revenues, net 3,634 4,779  
Cost of revenue 3,347 3,561  
Depreciation and amortization expense 804 306  
Income (loss) from operations, before income taxes (1,655) (1,029)  
Total assets 23,773   38,358
Unallocated corporate      
Segment Reporting Information [Line Items]      
Income (loss) from operations, before income taxes (3,831) $ (2,804)  
Total assets $ 23,963   $ 9,348